DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Alembic Pharmaceuticals Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 2 hrs ago·27 Jul 2026, 12:30 pm

Alembic Pharma

Alembic Pharmaceuticals has announced it will hold a post-results conference call on August 4, 2026. This is a routine event where company management discusses their latest quarterly performance and future outlook with analysts and investors.

This update is significant for retail investors as it provides a direct opportunity to hear management's perspective on the business. It helps clarify any uncertainties following the earnings release and offers insights into the company's strategic direction.

Investors should watch for management's commentary on operational efficiency, growth drivers, and any guidance provided for upcoming quarters. This information is crucial for assessing the stock's future potential.